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the amebae in plant B’s water suggests the importance of 
enhanced chlorine pumping at distribution points beyond 
water treatment plants for maintain residual chlorine in 
Karachi’s domestic water supply.
Because water supply can be intermittent, under-
ground and overhead storage tanks are essential for Kara-
chi homes. To ensure continuous domestic supply, water 
is stored in overhead tanks and pumped from tanks into 
homes as needed. Water storage in tanks perhaps facili-
tated propagation of N. fowleri amebae in domestic and 
mosque water. During the summer, ambient temperatures 
reach 44°C, leading to increased water temperatures in 
overhead tanks. We found water temperatures up to 34°C, 
which may facilitate excystation of N. fowleri amebae to 
infective forms. Slime, dirt, and high ambient tempera-
tures likely explain N. fowleri multiplication in storage 
tanks, the possible source of infection for this patient 
in Karachi.
Presence of N. fowleri amebae in mosque water is 
alarming. Ablution (Wudhu) is a ritual performed by Mus-
lims before offering prayers and involves thorough clean-
ing of mouth, ears, face, arms, feet, and nasal passages, the 
latter by inhaling water forcefully up the nostrils. Perform-
ing this activity with contaminated water could be a com-
munal source for potential outbreaks.
Karachi water supply authorities have initiated chlo-
rine enhancement at various sites beyond plant B, and our 
findings support the need for this enhancement. We recom-
mend that the government implement measures to maintain 
appropriate chlorine levels in the domestic water supply 
and at recreational sites and to develop effective amebae-
monitoring programs. The public should use boiled or 
filtered water for nasal cleansing, regularly clean storage 
tanks, and add supplemental chlorine to water in homes, 
especially during the summer.
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To the Editor: Chikungunya virus (CHIKV) has be-
come a global health problem. Clinical manifestations are 
not specific and are difficult to differentiate from those 
of similar viral diseases (e.g., dengue and Zika virus dis-
ease). Diagnostic laboratories must be prepared to meet the 
changing epidemiology of viral diseases. CHIKV infection 
is currently identified by viral genome detection, using re-
verse transcription PCR (RT-PCR), viral culture, and sero-
logic testing for IgG and IgM by indirect immunofluores-
cence (IFA) or ELISA. RT-PCR is most sensitive during 
the early phase of CHIKV infection (within 5–7 days of 
symptom onset), but its use is limited by the short viremic 
phase of the disease. After the acute phase, serologic test-
ing for IgG and IgM is a more accurate indicator of disease. 
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Molecular and serologic tests are complementary, reliable, 
and sensitive methods, but they require special equipment 
and a medium-to-high level of technical skill that may not 
be available in many laboratories, especially those in rural 
areas, where outbreaks usually occur.
Accurate and rapid detection of CHIKV infection by 
reliable point-of-care (POC) assays has been recommend-
ed to facilitate outbreak control. To meet this need, rapid 
CHIKV IgM POC tests are now available, but little infor-
mation exists regarding their performance. The sensitivity 
of these tests evaluated in settings with a high prevalence 
of CHIKV infection is poor (range 1.9%–50.8%) compared 
with that for reference assays, especially in the acute phase 
of disease (1–5). In low-prevalence settings, CHIKV infec-
tion generally occurs as imported cases in travelers return-
ing from disease-endemic countries. Diagnosis of such cas-
es requires discrimination between CHIKV, dengue, Zika, 
and other febrile diseases in the differential diagnosis; this 
discrimination could be facilitated by the use of a reliable 
POC assay. The recent Zika virus disease outbreak in South 
America also highlights the worldwide need for rapid reli-
able POC tests.
From June 2014 through November 2015, eight pa-
tients who had returned to Italy from the Caribbean and 
Latin America were referred to the regional Center for 
Infectious Diseases, Amedeo di Savoia Hospital, in Turin 
for travel-associated CHIKV infection. These cases were 
the first in the region after 3 years without imported cases. 
We used IFA (Euroimmun AG, Lubek, Germany) and real-
time RT-PCR (TIB MOLBIOL GmbH, Berlin, Germany) 
for CHIKV diagnosis. In addition, we evaluated the OnSite 
Chikungunya IgM Combo Rapid Test CE (CTK Biotech, 
San Diego, CA, USA) for CHIKV infection.
The rapid test identified IgM in only 3 of 8 patients 
(sensitivity 37.5%). All patients were negative for viral 
RNA, probably due to the time elapsed between symp-
tom onset and serum sample collection, as confirmed by 
the presence of CHIKV IgG in most patients. No false-
positive or invalid results were recorded with the rapid 
test on 30 CHIKV-negative serum samples (specificity 
100%; positive and negative predictive values 37.5% and 
100%, respectively).
Rapid and appropriate diagnostic tools are needed to 
slow or stop the worldwide spread of CHIKV. Rapid POC 
tests are highly cost-effective because they are easy to per-
form and can be disseminated to many laboratories for dif-
ferentiating between diseases that are similar. Moreover, 
their results can easily be evaluated and shared within net-
works of reference laboratories.
However, our findings, in agreement with those of oth-
ers, show that current rapid CHIKV tests perform poorly 
and need major improvement (Table) (1–5). This poor per-
formance might have several explanations. For example, 
CHIKV patients do not often seek medical care in the ear-
ly course of the disease. Most patients in our study were 
no longer in the acute phase of illness: the diagnosis was 
made a mean of 16.8 (range 7–30) days after fever onset, 
and when tested, all patients were viral RNA–negative by 
real-time RT-PCR. POC reactivity generally increases in 
patients with illness duration of >1 week (1–5), but this 
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Table. Reported sensitivity and specificity of rapid point-of-care tests for detecting chikungunya virus, 2008–2015* 
Reference and test(s) 
Time from 
symptom onset 
to testing, d 
Sensitivity, 
%‡ 
Specificity, 
%‡ Test reference standard 
(1)     
 OnSite Chikungunya IgM Rapid Test 1 to >21 20.5 100 Capture ELISA IgM (in house) with 
Asian lineage virus; rRT-PCR 
 SD BIOLINE Chikungunya IgM test 1 to >21 50.8 89.2 Capture ELISA IgM (in house) with 
Asian lineage virus; rRT-PCR 
(2)     
 SD BIOLINE Chikungunya IgM test <7; 8 to >14§ 22; 83 88; 71 ELISA IgM; rRT-PCR  
(3)     
 OnSite Chikungunya IgM Rapid Test 3.75 to >7 12.1 100 IgM IFA; capture ELISA IgM (in 
house); rRT-PCR  
(4)     
 SD BIOLINE Chikungunya IgM test 3–8 1.9–3.9 92.5–95.0 Capture ELISA IgM; rRT-PCR  
(5)     
 OnSite Chikungunya IgM Combo Rapid Test CE NA 20 93 Capture ELISA IgM/IgG (in house); 
plaque reduction neutralization test 
 SD BIOLINE Chikungunya IgM test NA 30 73 Capture ELISA IgM/IgG (in house); 
plaque reduction neutralization test 
This study      
 OnSite Chikungunya IgM Combo Rapid Test CE 7 to 30 37.5 100 IFA IgM/IgG (commercial); rRT-PCR  
*IFA, indirect immunofluorescence assay; NA, not applicable; rRT-PCR, real-time reverse transcription PCR. 
†Manufacturers: CTK Biotech, San Diego, CA, USA (OnSite Chikungunya IgM Combo Rapid Test CE and OnSite Chikungunya IgM Rapid Test); Standard 
Diagnostics, Inc., Seoul, South Korea (SD BIOLINE Chikungunya IgM test). 
‡Values are those reported in the original publications. 
§Testing was done at 2 different time points after symptom onset. 
 
was not the case in our study. Genetic differences in cir-
culating CHIKV lineages could also explain poor testing 
performance. Furthermore, the OnSite Chikungunya IgM 
Combo CE POC test uses a recombinant antigen covering 
the 226 residues of the E1 gene from CHIKV variant A226; 
recent studies on CHIKV protein characterization showed 
that more sensitive serologic assays can be obtained using 
specific early-phase E2 glycoprotein as antigens (3). 
The successful use of rapid immunochromatography-
based assays with monoclonal antibodies to detect viral 
diseases (e.g., dengue) has encouraged the development of 
rapid immunoassays for CHIKV antigens, and preliminary 
results for these assays seem promising (6). External qual-
ity assessment programs for POC tests and quality controls 
consisting of standardized positive serum could also be 
helpful for improving the performance of diagnostic tests.
In conclusion, returning travelers are sentinels of the 
rapidly changing epidemiology of CHIKV; thus, they re-
quire a prompt diagnosis and careful surveillance for their 
possible role in subsequent autochthonous disease trans-
mission. Implementation of user-friendly, rapid, and easily 
deliverable POC tests for a prompt and accurate laboratory 
diagnosis is therefore needed to improve patient manage-
ment and disease control measures.
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To the Editor: Circular replication initiation protein 
(Rep)–encoding single-stranded DNA (ssDNA) (CRESS-
DNA) genomes are found in diverse group II virus fami-
lies, which all possess a conserved Rep-encoding gene 
and a nonenveloped icosahedral capsid, except gemini-
viruses, which have twinned particles (1). Gemycircu-
larvirus (GcV) were initially discovered in fungi, but a 
growing number of new species has been characterized 
by metagenomics in air, sewage, insects, and feces from 
a broad range of vertebrates (1–5). GcVs have also been 
found in the brain and serum of humans with multiple 
sclerosis; in the cerebrospinal fluid of a patient with en-
cephalitis; and in several blood samples, including those 
from an HIV-positive blood donor (6–8). We report the 
presence of 2 divergent GcVs and a novel CRESS-DNA 
virus (CV) in 2 pericardial fluid samples from a patient 
with idiopathic recurrent pericarditis.
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